RUNX3 mediates suppression of tumor growth and metastasis of human CCRCC by regulating cyclin related proteins and TIMP-1

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  He, Lijie ^a   Zhao, Xiaodi ^a   Wang, Hanmin ^a   Zhang, Peng ^a   Guo, Changcun ^a   Huang, Chen ^a   Liu, Xiaowei ^a   Yao, Fangfang ^a   Chen, Yu ^a   Lou, Weijuan ^a   Sun, Shiren ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; RETINOBLASTOMA PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR RUNX3; CYCLINE; RUNX3 PROTEIN, HUMAN; TIMP1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER REGRESSION; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; PROTEIN TARGETING; UPREGULATION; ANIMAL; CELL DIVISION; FLOW CYTOMETRY; KIDNEY TUMOR; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MUS MUSCULUS;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL DIVISION; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CYCLINS; FLOW CYTOMETRY; HUMANS; KIDNEY NEOPLASMS; MICE; MICE, NUDE; NEOPLASM METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84863346589     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032961     Document Type: Article

References (31)

1. Zbar B, Klausner R, Linehan WM, (2003) Studying cancer families to identify kidney cancer genes. Annu Rev Med 54: 217-233.
2. Ibanez DCI, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, et al. (2006) Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res 66: 5021-5028.
3. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, et al. (2002) Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-124.
4. Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, et al. (2005) RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 65: 7743-7750.
5. Kim WJ, Kim EJ, Jeong P, Quan C, Kim J, et al. (2005) RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res 65: 9347-9354.
6. Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, et al. (2004) Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 23: 6736-6742.
7. Meng Y, He L, Guo X, Tang S, Zhao X, et al. (2010) Gankyrin promotes the proliferation of human pancreatic cancer. Cancer Lett 297: 9-17.
8. Wang J, Wu K, Zhang D, Tang H, Xie H, et al. (2005) Expressions and clinical significances of angiopoietin-1,-2 and Tie2 in human gastric cancer. Biochem Biophys Res Commun 337: 386-393.
9. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, et al. (1994) HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45: 48-57.
10. Tan XY, Zheng FL, Zhou QG, Duan L, Li Y, (2005) [Effect of bone morphogenetic protein-7 on monocyte chemoattractant protein-1 induced epithelial-myofibroblast transition and TGF-beta1-Smad 3 signaling pathway of HKC cells]. Zhonghua Yi Xue Za Zhi 85: 2607-2612.
11. Guo C, Ding J, Yao L, Sun L, Lin T, et al. (2005) Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. Int J Cancer 116: 155-160.
12. Chen Y, Wei X, Guo C, Jin H, Han Z, et al. (2010) Runx3 suppresses gastric cancer metastasis through inactivation of MM9 by up-regulation of TIMP-1. Int J Cancer.
13. van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD, (2000) RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 60: 5832-5838.
14. Liu N, Bi F, Pan Y, Sun L, Xue Y, et al. (2004) Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res 10: 6239-6247.
15. He L, Wang H, Jin H, Guo C, Xie H, et al. (2009) CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma. Cancer Lett 276: 88-94.
16. Meng Y, He L, Guo X, Tang S, Zhao X, et al. (2010) Gankyrin promotes the proliferation of human pancreatic cancer. Cancer Lett 297: 9-17.
17. Xue Y, Bi F, Zhang X, Pan Y, Liu N, et al. (2004) Inhibition of endothelial cell proliferation by targeting Rac1 GTPase with small interference RNA in tumor cells. Biochem Biophys Res Commun 320: 1309-1315.
18. Pan Y, Zhao L, Liang J, Liu J, Shi Y, et al. (2006) Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J 20: 1886-1888.
19. Peng Z, Tang H, Wang X, Zhou C, Fan J, et al. (2008) Inhibition of the growth and metastasis of human colon cancer by restoration of RUNX3 expression in cancer cells. Int J Oncol 33: 979-984.
20. Tsunematsu T, Kudo Y, Iizuka S, Ogawa I, Fujita T, et al. (2009) RUNX3 has an oncogenic role in head and neck cancer. PLoS One 4: e5892.
21. Weinberg RA, (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
22. Sherr CJ, (1996) Cancer cell cycles. Science 274: 1672-1677.
23. Malumbres M, Barbacid M, (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9: 153-166.
24. Mithani SK, Balch GC, Shiou SR, Whitehead RH, Datta PK, et al. (2004) Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells. J Surg Res 117: 296-305.
25. Malumbres M, Barbacid M, (2006) Is Cyclin D1-CDK4 kinase a bona fide cancer target? Cancer Cell 9: 2-4.
26. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G, (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7: 812-821.
27. Li W, Kotoshiba S, Berthet C, Hilton MB, Kaldis P, (2009) Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G1/S transition. Proc Natl Acad Sci U S A 106: 486-491.
28. Sherr CJ, Roberts JM, (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
29. Cho JY, Chung HC, Noh SH, Roh JK, Min JS, et al. (1997) High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma. Cancer 79: 878-883.
30. Jin H, Pan Y, He L, Zhai H, Li X, et al. (2007) p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer. Mol Cancer Res 5: 423-433.
31. Okamoto T, Niu R, Yamada S, (2003) Increased expression of tissue inhibitor of metalloproteinase-2 in clear cell carcinoma of the ovary. Mol Hum Reprod 9: 569-575.